Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 293479, 4 pages
http://dx.doi.org/10.1155/2012/293479
Review Article

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma

1Disciplina de Hematologia e Hemoterapia, Departamento de Oncologia Clínica e Experimental, Campus São Paulo, UNIFESP, Rua Botucatu 740, 3o Andar, 04023-900 São Paulo, SP, Brazil
2Department of Oncology and Hematology and Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany

Received 6 December 2011; Accepted 12 February 2012

Academic Editor: Nicolaus Kröger

Copyright © 2012 Walter M. T. Braga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Atanackovic, Y. Cao, T. Luetkens et al., “CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation,” Haematologica, vol. 93, no. 3, pp. 423–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. K. C. Anderson, “New insights into therapeutic targets in myeloma,” Hematology, vol. 2011, no. 1, pp. 184–190, 2011. View at Google Scholar
  3. G. Pratt, O. Goodyear, and P. Moss, “Immunodeficiency and immunotherapy in multiple myeloma,” British Journal of Haematology, vol. 138, no. 5, pp. 563–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. R. H. Prabhala, P. Neri, J. E. Bae et al., “Dysfunctional T regulatory cells in multiple myeloma,” Blood, vol. 107, no. 1, pp. 301–304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. H. Prabhala, D. Pelluru, M. Fulciniti et al., “Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma,” Blood, vol. 115, no. 26, pp. 5385–5392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Yuan, S. Gnjatic, H. Li et al., “CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 51, pp. 20410–20415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors rorα and rorγ,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Chen, W. Jin, N. Hardegen et al., “Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3,” Journal of Experimental Medicine, vol. 198, no. 12, pp. 1875–1886, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig, and H. von Boehmer, “Inducing and expanding regulatory T cell populations by foreign antigen,” Nature Immunology, vol. 6, no. 12, pp. 1219–1227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Zhou, J. E. Lopes, M. M. W. Chong et al., “TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing rorγt function,” Nature, vol. 453, no. 7192, pp. 236–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. X. O. Yang, R. Nurieva, G. J. Martinez et al., “Molecular antagonism and plasticity of regulatory and inflammatory T cell programs,” Immunity, vol. 29, no. 1, pp. 44–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “Il-17 and TH17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Dhodapkar, S. Barbuto, P. Matthews et al., “Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (TH17-1 cells) enriched in the bone marrow of patients with myeloma,” Blood, vol. 112, no. 7, pp. 2878–2885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. W. M. T. Braga, A. C. Carvalho, A. L. Vetore, D. Atanackovic, and G. W. B. Colleoni, “Evaluation of T regulatory and Th17 cells related-genes expression in bone marrow aspirates of solitary plasmocitoma and multiple myeloma patients,” Haematologica, vol. 96, supplement 1, p. 528, 2011. View at Google Scholar
  15. W. M. T. Braga, A. C. Carvalho, A. L. Vetore, D. Atanackovic, and G. W. B. Colleoni, “Overexpression of FOXP3 in bone marrow (BM) aspirates highlights the importance of regulatory T-cell subpopulations as possible therapeutic target in multiple myeloma,” Haematologica, vol. 96, supplement 1, p. 55, 2011. View at Google Scholar
  16. M. D. Sharma, D. Y. Hou, Y. Liu et al., “Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes,” Blood, vol. 113, no. 24, pp. 6102–6111, 2009. View at Publisher · View at Google Scholar · View at Scopus